PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mechanism underlying the ability of H3 receptor antagonist to treat brain edema

2013-08-12
(Press-News.org) Thioperamide, a selective histamine H3 receptor antagonist, can increase histamine content in the brain and improve brain edema in adult hypoxic rats. Brain edema is precisely considered as the important pathological change of neonatal hypoxic-ischemic encephalopathy. As a study reported in the Neural Regeneration Research (Vol. 8, No. 19, 2013), thioperamide was used to increase histamine content in the brain, and then the mechanism of action of thioperamide during brain edema in a rat model of neonatal hypoxic-ischemic encephalopathy was examined. Results showed that thioperamide significantly decreased brain water content and malondialdehyde levels, while significantly increased histamine levels and su-peroxide dismutase activity in the hippocampus. This evidence demonstrates that thioperamide could prevent oxidative damage and attenuate brain edema following neonatal hypoxic-ischemic encephalopathy. The researchers further found that the H1 receptor antagonist, pyrilamine, reversed the effects of thioperamide; however, the H2 receptor antagonist, cimetidine, had no significant influence on the effects of thioperamide. The researchers suggest that thioperamide can increase brain histamine content and attenuate brain edema and oxidative damage by acting in combination with postsynaptic H1 receptors in a rat model of neonatal hypoxic-ischemic encephalopathy.



INFORMATION:

Article: " Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors " by Feiyong Jia, Lin Du, Yunpeng Hao, Shicheng Liu, Ning Li, Huiyi Jiang (Division of Pediatric Neurorehabilitation, Department of Pediatrics, Second Part of First Hospital of Jilin University, Changchun 130031, Jilin Province, China)

Jia FY, Du L, Hao YP, Liu SC, Li N, Jiang HY. Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors. Neural Regen Res. 2013;8(19):1814-1822.

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/

Full text: http://www.sjzsyj.org:8080/Jweb_sjzs/CN/article/downloadArticleFile.do?attachType=PDF&id=652



ELSE PRESS RELEASES FROM THIS DATE:

Limb-girdle muscular dystrophy subtypes in the population of Northeast China

2013-08-12
The most common limb-girdle muscular dystrophy subtype in Italy, Spain, Turkey, Russia, Brazil and Australia is calpainopathy (limb-girdle muscular dystrophy type 2A), while dystroglycanopathy (limb-girdle muscular dystrophy type 2I) is the commonest form in Norway, Denmark and northern England. In India, sarcoglycanopthies (limb-girdle muscular dystrophy type 2C-2F) are the most preva-lent, while dysferlinopathies are the most frequent type in USA and Japan. A rigorous comparison of the morphological features of biopsy specimens between limb-girdle muscular dystrophy type ...

X-linked MeCP2 is first reported to be a new target for treating Parkinson's disease

2013-08-12
X-linked methyl-CpG binding protein 2 plays important role in the regulation of neuronal development, proliferation and maturation, and synaptic regeneration and apoptosis. Overexpression of X-linked methyl-CpG binding protein 2 in SH-SY5Y cells can reduce cell apoptosis induced by 6-hydroxydopamine and increased tyrosine hydroxylase expression. But the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson's disease remains unknown. Prof. Xianhou Yuan and team from Zhongnan Hospital of Wuhan University used 6-hydroxydopamine-induced human ...

Solutions for improving first aid in cardiorespiratory arrests

2013-08-12
An algorithm capable of diagnosing heart rhythm with just 3 seconds' worth of signal, and the demonstration that it is possible to come up with the diagnosis without stopping cardiac massage, constitute the types of solutions and proposals being developed by researchers in the Signal and Communications Group of the Faculty of Engineering in Bilbao (UPV/EHU-University of the Basque Country). "We don't save lives, we just do research," as Jesús Ruiz, leader of the Signal and Communications Group, makes it clear. "But what has been confirmed is that it is cardiac massage ...

Estrogen enhancers tied to aggressive breast cancer

2013-08-12
SAN ANTONIO -- Adding to the picture of what prompts breast cancers to form, researchers from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center San Antonio today announced that "distant estrogen response elements" (DEREs) can act independently of oncogenes to spur tumor development. DEREs appear to be depots or hubs that remotely and simultaneously control multiple target genes in response to estrogen stimulation, said Pei-Yin Hsu, Ph.D., lead author of the paper in Cancer Cell. As such, they are prime targets for the study of ...

Use of simple rule in children's ankle injuries reduces use of radiography by 22 percent

2013-08-12
Radiography is widely used in diagnosing ankle injuries, with 85%–95% in pediatric injuries, although only 12% of these show fractures. "Radiography is unnecessary for most children's ankle injuries, and these high rates of radiography needlessly expose children to radiation and are a questionable use of resources," writes Dr. Kathy Boutis, a pediatric emergency department physician at the Hospital for Sick Children (SickKids) and the University of Toronto, with coauthors. The Low Risk Ankle Rule is highly accurate at identifying fractures and can potentially reduce ...

'Dark-horse' molecule is a potential new anti-cancer target

2013-08-12
Contact: Vanessa Solomon solomon@wehi.edu.au 61-393-452-971 Walter and Eliza Hall Institute Rachel Steinhardt rsteinhardt@licr.org 212-450-1582 Ludwig Institute for Cancer Research 'Dark-horse' molecule is a potential new anti-cancer target Australian researchers have identified a molecule called interleukin-11 as a potential new target for anti-cancer therapies. Until now, the importance of interleukin-11 in cancer development has been underestimated, but researchers have recently identified this molecule as a 'dark horse' for the development of cancer. ...

Aggressive breast cancers may be sensitive to drugs clogging their waste disposal

2013-08-12
Boston, Mass., August 12, 2013 – In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins. These cancers, which lack the three major therapeutic markers for breast cancer—the estrogen, progesterone and HER2 receptors—are very aggressive and difficult to treat. They mostly affect younger women ...

Young or old, song sparrows experience climate change differently from each other

2013-08-12
What's good for adults is not always best for the young, and vice versa. At least that is the case with song sparrows and how they experience the effects of climate change, according to two recent studies by scientists at the University of California, Davis, and Point Blue Conservation Science. Both studies show the importance of considering the various stages and ages of individuals in a species -- from babies to juveniles to adults -- to best predict not only how climate change could affect a species as a whole, but also why. "To learn how climate change is expected ...

Singapore scientists unravel cancers linked to herbal remedies

2013-08-12
Singapore, 12 August 2013 – A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming. Using advanced DNA sequencing technologies, the team, led by Professors Teh Bin Tean, See-Tong Pang, Patrick Tan and Steve Rozen discovered that AA is the most potent carcinogen ...

Largest study of epilepsy patients ever conducted reveals new and surprising genetic risk factors

2013-08-12
NEW YORK, August 11 – Neurologists and epilepsy researchers from NYU Langone Medical Center were among scientists who have 329 random genetic mutations associated with two of the most severe forms of epilepsy, according to a paper published today in Nature. Though well-known that many forms of epilepsy are strongly influenced by genetics, there has been relatively little progress in identifying the genetic differences that contribute to most forms of epilepsy. This study sheds light on why some with an elevated risk for epilepsy never get the disease and why certain medications ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Mechanism underlying the ability of H3 receptor antagonist to treat brain edema